Stay Informed
Subscribe now to receive regular updates and never miss out on the latest news.
By submitting your email, you agree to our Terms of use and Privacy policy.

Walgreens Announces Launch of Affordable Naloxone HCI Nasal Spray for Opioid Overdose Reversal

Wednesday, 15 May 2024, 17:40
Walgreens is introducing a lower-priced version of the essential opioid reversal drug, Naloxone HCI Nasal Spray. Priced at $34.99, the Walgreens Brand Naloxone offers a cost-effective alternative to the national brand, emphasizing increased access and affordability for customers. The FDA's recent approvals, including making Narcan available over-the-counter, mark positive steps in combating the opioid epidemic.
https://store.livarava.com/738334e5-12e2-11ef-a6c2-63e1980711b2.jpg
Walgreens Announces Launch of Affordable Naloxone HCI Nasal Spray for Opioid Overdose Reversal

Walgreens to Make Naloxone HCI Nasal Spray More Accessible

Walgreens is set to introduce a cheaper version of the opioid reversal drug, Naloxone HCI Nasal Spray, providing customers with a more affordable option. The product, priced at $34.99, will be chainwide in all stores by the end of the month, emphasizing increased accessibility.

Affordability and Accessibility

  • Cost-Effective Option: Walgreens' pricing at $34.99 offers a more economical choice compared to national brands.
  • Enhanced Availability: The product will be available both online and in-store, ensuring widespread access for customers and patients.

Walgreens' initiative demonstrates a commitment to addressing the opioid crisis by providing a critical medication for opioid overdose reversal.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Do you want to advertise here?
Do you want to advertise here?
Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe